Innovative research to facilitate women’s health

Invent Medic develops and offers research-based products that contribute to more freedom, joy and an active lifestyle.
Read more about Invent MedicRead about Efemia

Interim report Q2 2020

“Sales growth despite Covid-19 shutdowns in the UK and Germany”

Annual report for 2019

“2019 was characterised by a commercial breakthrough for Efemia”

Press release September 14, 2020

”Kronans Apotek includes Efemia in its assortment”

Today, Efemia is available in several European markets including the UK and Germany, with over 8 million potential users in total. We are now working to include additional European markets and to prepare for a potential future launch in the United States, while also developing/evaluating additional products.

Karin Bryder

CEO, Invent Medic Sweden

Q2 2020

Forecast: Potential Efemia users

  • 2018 – 0.5 million (swe)
  • 2019 – 8 million (+dan, ger, uk, nor)
  • 2020 – 15 million (+ned, bel and more eu countries)
  • 2021 – 35 million (+the us and additional countries)

The forecast is based on Invent Medic’s expansion plans and an estimation of women with bothersome SUI in each market. In studies, around 70% of the participants have stated that they see themselves continue to use Efemia.